I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
6 versus 12 months of adjuvant trastuzumab for HER2-positiv..:
Earl, Helena M
;
Hiller, Louise
;
Vallier, Anne-Laure
...
https://www.repository.cam.ac.uk/handle/1810/290388. , 2019
Link:
https://www.repository.cam.ac.uk/handle/1810/290388
RT Journal T1
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
UL https://suche.suub.uni-bremen.de/peid=base-ftunivcam:oai:www.repository.cam.ac.uk:1810_290388&Exemplar=1&LAN=DE A1 Earl, Helena M A1 Hiller, Louise A1 Vallier, Anne-Laure A1 Loi, Shrushma A1 McAdam, Karen A1 Hughes-Davies, Luke A1 Harnett, Adrian N A1 Ah-See, Mei-Lin A1 Simcock, Richard A1 Rea, Daniel A1 Raj, Sanjay A1 Woodings, Pamela A1 Harries, Mark A1 Howe, Donna A1 Raynes, Kerry A1 Higgins, Helen B A1 Wilcox, Maggie A1 Plummer, Chris A1 Mansi, Janine A1 Gounaris, Ioannis A1 Mahler-Araujo, Betania A1 Provenzano, Elena A1 Chhabra, Anita A1 Abraham, Jean E A1 Caldas, Carlos A1 Hall, Peter S A1 McCabe, Christopher A1 Hulme, Claire A1 Miles, David A1 Wardley, Andrew M A1 Cameron, David A A1 Dunn, Janet A A1 PERSEPHONE Steering Committee and Trial Investigators PB Elsevier BV; http://dx.doi.org/10.1016/s0140-6736(19)30650-6; Lancet YR 2019 K1 Adult K1 Aged K1 80 and over K1 Antineoplastic Agents K1 Immunological K1 Breast Neoplasms K1 Chemotherapy K1 Adjuvant K1 Disease-Free Survival K1 Drug Administration Schedule K1 Female K1 Humans K1 Infusions K1 Intravenous K1 Injections K1 Subcutaneous K1 Middle Aged K1 Prospective Studies K1 Receptor K1 ErbB-2 K1 Trastuzumab K1 Treatment Outcome K1 United Kingdom K1 Young Adult JF https://www.repository.cam.ac.uk/handle/1810/290388 LK http://dx.doi.org/https://www.repository.cam.ac.uk/handle/1810/290388 DO https://www.repository.cam.ac.uk/handle/1810/290388 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)